These findings provide new insights into the role of B1R in decreased compensatory activity of ACE2 in neurons and thus B1R can be a potential therapeutic target in promoting the balance towards beneficiary ACE2/Ang-(1–7) pathway in cardiovascular and neurodegenerative disease conditions. This evidence concerns the gene BDKRB1 and neurodegenerative disease.